Prolonged exposure to space environments poses significant health risks to space travelers, as the human body is biologically unprepared for such conditions. A large percentage of astronauts experience illness after relatively short periods in space, highlighting the need for countermeasures.

Laminomics is developing the Shepherd System, a health technology that leverages individual biodata to create personalized pharmaceutical products designed to protect and adapt individuals to the biohazards of space travel and extreme environments. The system provides individuals with tailored health insights, while also offering key stakeholders access to extensive biological datasets. Laminomics is also constructing LAM City, a self-sufficient Antarctic city-state, to simulate extraterrestrial conditions and test survival strategies, economic models, and health innovations crucial for future interplanetary settlement.

Personalized pharmaceutical recommendations based on individual genetic data

Biodata utilization for targeted drug development

Simulation of extraterrestrial conditions in a self-sufficient Antarctic city-state

Testing of survival strategies and health innovations for space exploration

Development of economic models for sustainable space settlements

The primary target audience includes space travelers, researchers, medical practitioners, and companies involved in space exploration and extreme environment adaptation.